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Abstract 
Aims: Tyrosine hydroxylase (TH) is the first and rate-limiting enzyme in 
catecholamine biosynthesis. Whereas the neuroendocrine roles of cathecolamines 
postnatally are well known, the presence and function of TH in organogenesis is unclear. 
The aim of this study is to define the expression of TH during cardiac development and 
to unravel the role it may play in heart formation. 
Methods and Results: We studied TH expression in chick embryos by whole 
mount in situ hybridization and by quantitative reverse transcription-polymerase chain 
reaction (RT-qPCR), and analyzed TH activity by high-performance liquid 
chromatography (HPLC). We used gain- and loss-of-function models to characterize the 
role of TH in early cardiogenesis. We found that TH expression was enriched in the 
cardiac field of gastrulating chick embryos. By stage 8, TH mRNA was restricted to the 
splanchnic mesoderm of both endocardial tubes and was subsequently expressed 
predominantly in the myocardial layer of the atrial segment. Overexpression of TH led 
to increased atrial myosin heavy chain (AMHC1) and T-box 5 gene (Tbx5) expression 
in the ventricular region, and induced bradiarrythmia. Similarly, addition of L-3,4-
dihydroxyphenylalanine (L-DOPA) or dopamine induced ectopic expression of cardiac 
transcription factors (cNkx2.5, Tbx5) and AMHC1, as well as sarcomere formation. 
Conversely, blockage of dopamine biosynthesis and loss of TH activity decreased 
AMHC1 and Tbx5 expression, whereas exposure to retinoic acid induced TH 
expression, in parallel to that of AMHC1 and Tbx5. Concordantly, inhibition of 
endogenous retinoic acid synthesis decreased TH expression as well as that of AMHC1 
and Tbx5.  
CVR-2010-9R1 
 3 
Conclusions: TH is expressed in a dynamic pattern during the primitive heart 
tube formation. TH induces cardiac differentiation in vivo and it is a key regulator of the 
heart patterning, conferring atriogenic identity. 
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  Introduction 
Catecholamines are hormones/neurotransmitters known to influence 
cardiovascular and endocrine physiology postnatally and processes such as movement, 
learning and emotional behaviour. TH is the first and rate-limiting enzyme in 
catecholamine biosynthesis. TH catalyzes the conversion of the amino acid L-tyrosine 
to L-3,4-dihydroxyphenylalanine (L-DOPA), which generates dopamine by the action 
of aromatic amino acid decarboxylase (AAADC). Subsequently, dopamine can be 
converted to noradrenaline, by the dopamine beta hydroxylase (DBH), and adrenaline in 
the mature nervous system and adrenal glands (Fig. 1A)
1
. Despite the well-characterized 
biological functions of catecholamines in postnatal organisms, very little is known 
about their function in embryonic development prior to neuronal differentiation. Early 
reports of the presence of the pathway members, and their pharmacological and genetic 
interference, revealed roles in gastrulation and early organogenesis
2
. Indeed, null-
mutations of TH and DBH caused embryonic lethality
3-5
 due to apparent heart failure. 
Although studies of the TH-null mice revealed a functional role of TH in maintaining 
oxygen homeostasis at mid-gestation stages
6,7
, the role of TH in early cardiogenesis 
remains unexplored.   
In vertebrates, the heart is initially formed by the fusion of the two bilateral 
endocardial tubes arising in the lateral plate splanchnic mesoderm. The resulting 
primitive heart tube, located at the ventral midline of the organism, undergoes a 
complex series of movements and tissue remodelling events that leads to the formation 
of the mature chambered organ
8
. Positional information for the formation of the atria 
and ventricles at specific sites within the heart tube, comes from the integration of the 
anterior-posterior, dorso-ventral and left-right patterning at early stages
9
. One of the 
first features of anterior-posterior patterning is the restriction of the ventricular myosin 
CVR-2010-9R1 
 5 
heavy chain (VMHC1) and atrial myosin heavy chain (AMHC1) to the anterior and 
posterior pole, respectively, of the heart tube
10-12
. In this study, we show that TH mRNA 
is enriched in the cardiac field of stage (st.) 5 chick embryos; by st. 8, TH expression 
was restricted to the splanchnic mesoderm of both endocardial tubes. Subsequently, TH 
localized predominantly to the myocardial layer of the posterior heart tube. Treatments 
with L-DOPA and dopamine induced ectopic expression of cardiac transcription factors 
and the contractile protein AMHC1, as well as sarcomere formation. Overexpression of 
TH led to the expansion of AMHC1 and Tbx5 expression into the anterior region, and 
induced bradiarrythmia. Inhibition of dopamine biosynthesis or knockdown of TH 
decreased AMHC1 and Tbx5 expression, and perturbed correct cardiac looping. 
Exposure to retinoic acid (RA) induced and expanded TH expression, as well as that of 
AMHC1 and Tbx5, whereas blockage of endogenous RA synthesis inhibited TH 
expression. Our results show that TH is expressed in a dynamic pattern during the 
primitive heart tube formation. TH induces cardiac differentiation in vivo and it is a key 
regulator of the heart patterning, conferring atriogenic identity. 
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Methods 
Experimental protocols with animals were performed in agreement with the 
Spanish law in application of the EU Guidelines for animal research, and conformed to 
the Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85-23). Approval by the CIB bioethics board 
was obtained prior to the initiation of the study. For details on the following methods, 
see supplementary materials online. 
Whole chick embryo culture and citral treatment. 
Fertilized eggs (Granja Santa Isabel, Córdoba, Spain) were incubated at 38 ºC in 
forced-draft, humidified incubators. Embryos were staged and cultured. For citral 
treatment, twenty microliters of test solution were applied over embryos at st. 5. 
Embryos were fixed in 4% PFA at st. 10-11 and processed for whole mount in situ 
hybridization (ISH). 
Embryo electroporation. 
St. 3 cultured embryos were injected and electroporated in the region determined 
to form the heart. For gain-of-function experiments the pCAGs- I-GFP (control) or 
pCAGs-TH-I-GFP vector was electroporated. For knock-down experiments, either 
fluorescein-labelled luciferase or TH morpholino oligonucleotide (MO) (Gene Tools 
LLC) was electroporated. After further 18-36 hour incubation, embryos were either 
fixed in 4% PFA and processed for whole mount ISH or the atria and ventricles were 
collected for RNA isolation.  
Bead implantation. 
Beads were soaked in the indicated solutions and implanted in the desired 
location at st. 5 (see Fig. 2A). After 6-18 hours of additional incubation, embryos were 
fixed in 4% PFA and processed for whole mount ISH or immunohistochemistry. 
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HPLC analysis. 
St.8 and st.10 embryos were processed to detect catecholamines by HPLC with 
colorimetric detection. 
ISH and Immunohistochemistry. Embryos were processed for ISH following 
standard procedures. The probes for cAMHC1, cVMHC1, Irx4, Bmp2 and cNkx2.5 
have been described. The cTH and cTbx5 probes, were generated by RT-PCR cloning. 
Whole mount immunohistochemistry was performed using the MF20 antibody followed 
by anti-mouse Ig-HRP antibody.  
RNA isolation and RT-qPCR. 
Total RNA was isolated with the Trizol reagent and reverse transcribed with the 
Superscript III and random primers (Invitrogen). qPCR was performed with the ABI 
Prism 7900HT Sequence Detection System (Applied Biosystems) by using TaqMan 
Universal PCR Master Mix, No-AmpErase UNG (Applied Biosystems) and the probes 
of the Universal Probe Library (URL, Roche Applied Science) were used for detection. 
Primer sequences and the respective URL probes are listed in supplementary material.  
Plasmids. 
The pCAGs-TH-I-GFP was generated by excising the TH cDNA from the 
pCRII-TOPO-TH, described above, with EcoRI and cloning it into the similarly 
digested pCAGs-I-GFP. 
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Results  
Early TH expression is localized to the developing heart and is active prior 
to its appearance in the nervous system. 
In postnatal organisms, TH is predominantly expressed in discrete areas of the 
brain, in the peripheral nervous system and in the adrenal gland. However, our 
identification of a dynamic pattern of TH expression in the early chick embryo
13
 led us 
to search for an as yet uncharacterized, preneuronal, function for TH. Whole mount ISH 
demonstrated that TH mRNA was expressed in st. 8 embryos, in the heart forming 
regions overlying the left and right endocardial tubes (Fig. 1B and S1). Transverse 
sections showed that TH mRNA was restricted to precardiac splanchnic mesoderm (Fig. 
1Ba). At st. 9, TH mRNA was found specifically in the fusing cardiac tubes and, once 
the primitive heart tube was formed, TH displayed a graded pattern of expression. TH 
transcripts were concentrated in the posterior part of the looping heart, the prospective 
atrial region (Fig. 1B, st. 12). Indeed, no transcripts were evident at the anterior pole of 
the looping heart (the prospective ventricular region: Fig. 1Bb), whereas TH expression 
was restricted to the myocardial layer at the posterior pole (Fig. 1Bc). This pattern of 
gene expression is remarkably similar to that of other genes that become progressively 
restricted to the posterior heart tube [e.g. AMHC1
10-12
 and Tbx5
14-16
, see figure S1 for 
better comparison]. Moreover, the distribution of TH transcripts coincided with that of 
TH protein (data not shown). 
The selective cardiac expression of TH was confirmed by RT-qPCR and TH 
mRNA was detected in gastrulating st. 5 embryos, prior to the time specific staining can 
be observed by whole mount ISH. TH transcript levels were 2-fold higher in the heart 
field of st. 5 embryos than in the total embryo (Fig. 1C) and, overall, TH transcript 
levels rose as development continued (approximately 2-fold between st. 5 and 8, and 4-
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fold between st. 8 and 10). This increase was more noticeable in the cardiac region, 
particularly between st. 5 and st. 8, in accordance with the distribution observed by ISH.  
TH activity depends on allosteric factors and on the phosphorylation state of the 
enzyme, as well as on the presence of co-factors
1,17
. To asses whether TH was active at 
these early embryonic stages, we measured catecholamine levels by HPLC in whole 
embryos at the endocardial, linear and looped tube stages (st. 8, 10 and 12, respectively). 
We chose not to dissect cardiac tissue to avoid material losses. L-DOPA was detected at 
st. 8 and their levels increased throughout cardiac development (Fig. 1D). Dopamine 
was detected only occasionally at st. 8, 10 and 12, and noradrenaline and adrenaline 
were not found at these embryonic stages. To explain the absence of catecholamines 
downstream of dopamine, we analyzed the expression of DBH. We could only detect 
DBH mRNA by RT-qPCR, and no specific signal by ISH was obtained. At all the 
stages analyzed, much lower levels of DBH mRNA than of TH mRNA were found 
(approximately 9, 80 and 190-fold lower at st. 5, 8 and 10, respectively). These 
differences were even greater (from 12 to 900-fold) in the cardiac region, indicating that 
the precursor L-DOPA and small amounts of dopamine are the principal, or perhaps the 
only, catecholamines present in the embryo prior to neuronal differentiation. The facts 
that dopamine is an unstable metabolite and the HPLC method is less sensitive for 
dopamine than for L-DOPA detection may account for the irregular detection of the 
former. These results extend previous findings, using less sensitive assays, where TH 
activity in the chick embryo was detected on the first day of incubation (st. 8), yet DBH 
activity was not evident until st. 19-20
18
. 
L-DOPA and dopamine induce cardiac differentiation. 
The pattern of TH expression and the presence of catecholamines suggested that 
TH and L-DOPA, and/or dopamine, play a role in cardiac development. We thus 
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implanted heparine-acrylamide beads soaked in either L-DOPA (10 mol/L) or 
dopamine (10 mol/L) lateral to one of the bilateral heart fields in embryos cultured at 
st. 5 (Fig. 2A, yellow bead). These embryos were allowed to develop until the linear or 
looped heart stage (st. 10 and 12, respectively), and were subsequently analyzed by 
whole mount ISH. St. 12 was the furthest developmental stage analyzed because the EC 
culture interferes with normal development beyond this stage. L-DOPA and dopamine 
induced expression of the cardiac transcription factors Nkx2.5 and Tbx5 in the ectopic 
tissue adjacent to the bead (Fig. 2A and Table S1). Moreover, expression of AMHC1, a 
sarcomeric protein and marker of terminal cardiac differentiation
10,12
, was also induced, 
as seen by ISH and by immunohistochemistry with the MF20 antibody. The cells of the 
induced ectopic tissue adjacent to the bead developed myofibrils organized into 
sarcomeres, similar to those found in the cardiomyocytes of the primitive heart tube 
(Fig. 2B). No ectopic tissue or ectopic expression of cardiac genes was provoked by 
control beads (Fig. 2A), ruling out the possibility that implantation of the bead alone 
triggered ectopic cardiogenesis. This also argues against the possibility that the bead 
acts as a physical barrier for an inhibitory signal, and suggests that exogenous L-DOPA 
and dopamine can stimulate cardiomyocyte differentiation. Preliminary studies show 
that dopamine beads also induce the expression of Bmp2 (Fig. S2), linking TH to early 
cardiac differentiation programs
19
. 
We further confirmed this hypothesis by blocking the endogenous synthesis of 
L-DOPA and dopamine. Accordingly, beads soaked in either 3-iodo-tyrosine (3I-Tyr, 1 
mmol/L), an inhibitor of TH, or in meta-hydroxybenzylhydrazine (mHBH, 1 mmol/L), 
an inhibitor of L-DOPA decarboxylase (Fig. 1A), were implanted medial to one of the 
bilateral heart fields of cultured embryos at st. 5 (Fig. 2A, red bead). Blockage of L-
DOPA, and more clearly of dopamine, biosynthesis led to an ipsilateral decrease of 
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AMHC1 expression in the endocardial tube at st. 8 (Fig. 2C and Table S2). These 
results suggest that dopamine synthesis is necessary for the correct expression of 
AMHC1.  
Overexpression and knock-down of TH modified the limits of the cardiac 
chambers. To gain further insight into the role of TH in cardiac differentiation, we 
performed gain-of-function experiments. A bicistronic construct containing the chicken 
TH cDNA and the GFP cDNA (pCAGs-TH-I-GFP) was injected and electroporated, 
into the cardiac progenitor cells that were migrating through the primitive streak of st. 3 
embryos. As a control, we used a vector containing the GFP cDNA alone (pCAGs-I-
GFP). Analysis of TH expression in pCAGs-TH-I-GFP electroporated embryos 
confirmed that TH mRNA and protein coincided with GFP expression (Fig. S3). In 
addition, there was an increase in L-DOPA levels measured by HPLC in embryos 
overexpressing TH (data not shown). Consistent with the myocardiogenic stimulatory 
effect of the L-DOPA and dopamine beads (Fig. 2A), the embryos overexpressing TH 
displayed a marked increase in AMHC1 expression when compared with control 
electroporated or non-electroporated embryos, particularly at the stages of heart tube 
fusion and looping (st. 10 and 12, respectively; Fig. 3A). In addition, the domain of 
AMHC1 expression at the looped heart tube stage (st. 12) had expanded abnormally 
towards the anterior pole of the primitive heart tube (Fig. 3A). To further characterize 
the changes in the developing heart, we analyzed the expression of Tbx5. This T-box 
family transcription factor is expressed in cardiac progenitors and, as development 
proceeds, it is found in a graded fashion along the heart tube with the highest levels in 
the sino-atrial region
14-16
. Significantly, the pattern of Tbx5 expression in these tissues 
very closely resembles that of TH and AMHC1 (Fig. S1). Like AMHC1 expression, 
Tbx5 expression expanded abnormally towards the anterior region of the heart tube in 
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TH-overexpressing embryos (Fig 3A, Table S3). Moreover, RT-qPCR analysis of 
dissected ventricles showed a 6-fold increased of AMHC1 levels in TH overexpressing 
embryos when compared to control electroporated ventricles (Fig 3B). Tbx5 expression 
increased more modestly (not statistically significant) similarly to what was also 
observed by ISH. 
 We then analyzed the effect of TH on the expression of the ventricular myosin 
heavy chain, VMHC1, initially expressed throughout the entire heart tube and 
downregulated in the atria after the looping stage (st. 12-13)
11,12,20
. VMHC1 became 
restricted to the anterior region of the heart tube of TH-overexpressing embryos (Fig. 
3C, Table S4). Likewise, the expression of the transcription factor Irx4, which is 
involved in specifying the prospective ventricular region
20
, regressed anteriorly (Fig 3C), 
suggesting that TH confers a posterior character on the looping heart tube. 
Overexpression of TH also had major functional consequences, since TH-
electroporated embryos displayed characteristics compatible with bradyarrythmia (see 
movie online). When recorded in culture, the heart rate of control electroporated 
embryos at st. 11 was 100 beats per minute (bpm), compared to 53 bpm in TH-
overexpressing embryos (Table 1). In addition, TH-electroporated embryos displayed 
arrhythmic heart beats (see movie online).  
To further confirm that TH is a fundamental element in cardiac development, we 
knocked down TH expression. A TH MO or luciferase MO as a control, were 
electroporated into the cardiac progenitor cells migrating through the primitive streak of 
st. 3 chick embryos. The TH morphants displayed a decrease in the expression of the 
atrial markers AMHC1 and Tbx5 (Fig. 4A). Conversely, the expression of VMHC1 in 
the most affected embryos was increased (Fig. 4A). In parallel, the silencing of TH 
expression diminished the atrial segment area and oversized the ventricular segment 
CVR-2010-9R1 
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(Fig. 4B, Table S5). Similar anterior-posterior heart patterning disruption was observed 
when retinoic acid signaling was inhibited
21
. Additionally, the progress of cardiac 
morphogenesis was very limited: TH morphants displayed a globular cardiac tube that 
did not form a fully looped tube (Fig. 4B), and the dysmorphic hearts barely beat (data 
not shown). 
TH action is linked to retinoic acid patterning effect. 
To integrate these findings into what is already known about heart 
morphogenesis, we turned to the effect of retinoic acid (RA) known to be involved in 
cardiac patterning. In vertebrates, the anterior-posterior identity of the primitive heart 
tube is established by RA signaling
22
. The documented posteriorization of RA
12,16,21,23,24
 
and that of TH described here, together with the fact that TH gene expression and 
activity are positively regulated by RA in the nervous system and adrenal gland
25,26
, 
suggested that TH might be a putative downstream target of RA activity in establishing 
the anterior-posterior heart tube axis. We tested this hypothesis by implanting beads 
soaked in RA (10 g/ml) into the heart field of cultured embryos at st. 5. RA expanded 
the expression of TH mainly in the ipsilateral inflow tract, as well as rostrally within the 
heart tube. A parallel effect was observed on the expression of AMHC1 and Tbx5 (Fig. 
5A, Table S6). To further support that TH expression is under RA control, we inhibited 
endogenous RA synthesis with citral. Accordingly, cultured embryos treated at st. 5 
with citral (10 mmol/L) displayed a dramatic decreased in TH expression parallel to 
diminished AMHC1 and Tbx5 expression (Fig. 5B, Table S7). 
Discussion 
The results presented here indicate that TH/L-DOPA/dopamine are involved in 
the network of signals that drive cardiac precursor cells to a sino-atrial fate, specifically 
by regionalizing Tbx5 and AMHC1 expression to the posterior part of the heart tube.  
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In st. 5 chick embryos, TH mRNA was enriched in the cardiac field; by st. 8, TH 
expression localized to the splanchnic mesoderm of endocardial tubes and it 
progressively became restricted to the sino-atrial region. Perturbing graded TH 
expression altered atrial and ventricular myosin segregation. Thus, while an increase in 
TH levels resulted in expansion of the AMHC1 and Tbx5 atrial domains and regression 
of the VHMC1 and Irx4 ventricular domains, loss of TH activity decreased AMHC1 
and Tbx5 expression, and occasionally increased VMHC1 expression. The less 
widespread VMHC1 expansion phenotype indicates that other factors are probably 
involved in restricting VMHC1 expression. Significantly, it has been shown that the 
graded expression of Tbx5 is crucial for the correct cranio-caudal patterning of the 
primitive heart tube, since disruption of this pattern results in abnormalities in heart 
chamber formation
14-16
. Indeed, the Holt-Oram syndrome in humans (with structural 
cardiac and conduction anomalies) is associated with mutations in the TBX5 gene
27-29
. 
The graded expression of Tbx5 and the posterior identity of the primitive heart tube are 
maintained by RA. An excess of RA causes expansion towards the anterior region of 
genes that are normally concentrated to the posterior region (i.e. Tbx5 and AMHC1), 
together with hyperplasia of the sino-atrial region
12,16,21,24
. Conversely, inhibition of RA 
signaling impairs development of the sino-atrial region and enlarges that of the 
ventricular region
21,23
. In our model system, we uncover a link between RA and TH 
action as suggested by the parallelism in the effect of blockage of endogenous TH 
expression and inhibition of RA signaling
21
, together with the fact that RA controled 
TH expression. Thus, according to these results, TH appears to reinforce the genetic 
program of the sino-atrial region, in a scenario where RA modulates the graded TH 
expression in the heart tube. In concert, TH activity favors the restriction of Tbx5 and 
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AMHC1 expression to the posterior heart tube, while suppressing Irx4 and VMHC1 in 
the prospective atria (Fig 5C).  
Alteration of TH expression (gain or loss) had also important functional 
consequences. Increased TH expression led to low rate and arrhythmic heart beating 
while loss of TH activity caused partial looping and discontinuous beating of the heart 
tube. The cause of this abnormal functionality is an open question. Previous studies 
have shown that restricting expression of contractile proteins to the ventricular and atrial 
chamber, including that of the myosin heavy and light chains, is essential for normal 
cardiac function
30-32
. Given that TH overexpression alters the distribution of atrial and 
ventricular myosin heavy chain isoforms, this could be at least partially responsible for 
some of the heart function abnormalities found in the TH-overexpressing embryos. 
Nevertheless, we are tempted to speculate that TH might be involved in specifying the 
cardiac pacemaker of the embryonic heart. In the chick, the pacemaker differentiates at 
around st. 9-10 in the posterior most segment of the primitive heart tube
33
, assuring the 
rhythmic propagation of the action potential with posterior-anterior polarity. The 
bradyarrythmia of the TH-overexpressing embryos, together with the restriction of TH 
expression to the sino-atrial region, are compatible with the interpretation that the 
gradient of TH activity in the primitive heart tube may be part of the signals leading to 
the dominance of the pacemaker in the posterior tube. This phenomenon could also be 
responsible for the development of the prospective sino-atrial node responsible for the 
pacemaker activity in the adult heart. This hypothesis is consistent with Pollack’s 
proposal several decades ago
34
 (reviewed by Ebert
35
)  that catecholamines are essential 
for cardiac pacemaker specification. Future experiments analyzing the expression of 
early pacemaker genes, among others, should clarify the role of TH in the pacemaker 
specification.  
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Generation of the catecholamine depleted mice models (TH and DBH 
knockouts)
3-5
 have  more recently shown that catecholamines are essential for embryo 
survival beyond mid-gestation. The catecholamine deficient mice die from apparent 
heart failure starting at E11.5-12.5, and the heart of surviving embryos is able to beat 
autonomously with slight bradycardia. Albeit the penetrance of the lethal phenotype 
was variable and some null-mice survived to term, recent reports have shown that 
catecholamines, in particular noradrenaline, mediate fetal survival by maintaining 
oxygen homeostasis in mid-gestation
6,7
. Moreover, restoration of noradrenaline, 
although not of dopamine, synthesis in the noradrenergic cells is sufficient to prevent 
lethality
36
. Using the chick embryo as a maternally-independent vertebrate model, we 
show that catecholamines, in particular dopamine, also have an earlier role in cardiac 
morphogenesis. Similar to our results in the chick embryo, in the study by Thomas et 
al.
4
 dopamine was the only catecholamine detected in E9.5 mouse embryos (long before 
the lethality occurred). In fact, we could detect TH expression in the whole mouse 
embryo since gastrulation stage at E6.5 and in the heart since E8.5 (the earliest stages 
analyzed) (Fig. S3). Our results are compatible with the findings in mice: dopamine 
plays an important role in early cardiac tube formation, whereas noradrenaline can be 
essential for mid-gestation fetal survival. Moreover, the apparent absence of major 
histological alterations in the catecholamine null-mice could be due to the presence of 
compensatory factors, including a potential contribution of maternal catecholamines
4
 or 
to species variation. A detailed characterization of the phenotype in mouse 
organogenesis would be required to unravel the role of all catecholamines in mouse 
cardiogenesis.  
Here, we have shown a strong concordant phenotype in TH-gain and loss-of-
function experiments in chick embryos. The remarkable change in the pattern of 
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electrical activation in the TH-overexpressing hearts is also consistent with the 
identification of intrinsic catecholamine-synthesizing cardiac cells, in human and rodent 
hearts, prior to inervation
37,38
. In mice and rats, cardiac catecholaminergic cells appear 
to be associated with the pacemaker and conduction system in four-chamber hearts
37
.  
The three dimensional requirements of cardiac development need complex 
signalling networks to lead cells through the appropriate fate decisions and 
morphogenetic movements
8,39
. In addition, antero-posterior polarity plays a role in the 
coupling between heart and blood vessels. Here, we reveal a novel function of TH in 
cardiac development, and suggest that TH may be a key player acting in concert with 
additional factors to define multiple aspects of chamber identity, including pacemaker 
specification. These results are consistent with the paradigm whereby molecules that act 
as intercellular signaling mediators, with well-defined restricted roles in postnatal 
organisms, are present at embryonic stages, when they participate in diverse functions 
often unrelated to their later roles (reviewed in
40,41
). The relevance of TH in human 
cardiogenesis and the possible significance of TH pathway alterations in cardiac 
syndromes may be a field deserving further studies. 
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Figure Legends 
Figure 1. Tyrosine hydroxylase expression and activity in developing chick 
embryos. A. The catecholamine biosynthesis pathway. B. Whole-mount ISH for TH at 
stages 8-12. a, b and c correspond to transverse paraffin sections at the levels indicated 
by the corresponding lines. Note that at st. 8 TH mRNA is restricted to the splanchnic 
mesoderm of the endocardial tubes, and later it is predominantly expressed in the 
myocardial layer of the atriogenic region (arrows in a and c). C. RT-qPCR of RNA from 
whole embryos at stages 5, 8 and 10 or from their corresponding cardiac regions. The 
levels of TH mRNA were normalized to GAPDH mRNA levels. The results represent 
the mean ± SD of three experiments. D. L-DOPA was measured by HPLC in extracts 
from one pool of 30 st. 8 embryos, two pools of 15 st. 10 embryos and two pools of 10 
st.12 embryos. The results represent, except in st. 8, the mean ± SD.  
 Figure 2. Effect of L-DOPA and dopamine, and their inhibition, on cardiac 
development. A. Effect of L-DOPA and dopamine on the expression of cardiac genes. 
Left drawing corresponds to a st. 5 embryo with a bead implanted lateral to one of the 
bilateral heart fields (yellow bead). Beads were soaked in either PBS (vehicle), or a 
solution of 10 mol/L L-DOPA or dopamine. Stage 10-12 embryos were subjected to 
whole-mount ISH for Nkx2.5, Tbx5 and AMHC1, or immunohistochemistry for MF20. 
Ectopic tissue adjacent to the bead coated with L-DOPA or dopamine (arrow) expressed 
all markers. Labelling was not detected around the control bead (arrowhead). B. 
Ultrastructure of the ectopic tissue induced by dopamine. Semi-thin sections of the bead 
area and ectopic tissue (a: 40x). Transmission electron microscopy of cells adjacent to 
the dopamine bead (b: 20,000x) or of cardiomyocytes in the primitive heart tube (c: 
10,000x). The white arrowheads indicate the Z bands, and the purple and yellow lines 
delineate the I and A bands, respectively. C. Effect of the inhibition of L-DOPA or 
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dopamine synthesis on AMHC1 expression. The position of the bead implanted medial 
to one of the bilateral heart fields of a st. 5 embryo is shown in 2A (red bead). Beads 
were soaked in either 3I-Tyr or mHBH, or the vehicle solution (NaOH and PBS, 
respectively). Embryos at st. 8 were analysed by whole-mount ISH for AMHC1. Note 
that AMHC1 expression is inhibited in the endocardial tube ipsilateral to the bead 
(arrow), but not by the control bead (arrowhead).  
Figure 3. Effect of TH on anterior-posterior heart tube patterning and 
specification of chambers. A. Effect of TH gain-of-function on sino-atrial gene 
expression. Whole-mount ISH for AMHC1 and Tbx5 in non-electroporated embryos, 
and in embryos electroporated with either the control construct (pCAGs-I-GFP) or with 
the TH expressing construct (pCAGs-TH-I-GFP). The anterior expanded expression of 
AMHC1 and Tbx5 in the heart tube is indicated by the black arrows. Visualization of 
GFP expression for the embryos processed for ISH is shown in the corresponding left 
panels. B. RT-qPCR of RNA from ventricles (V in scheme) of st. 12 embryos 
electroporated with either the control construct (pCAGs-I-GFP) or with the TH 
expressing construct (pCAGs-TH-I-GFP). The levels of AMHC1 and Tbx5 mRNA 
were normalized to GAPDH mRNA levels. The results represent the mean ± SEM of 
three pools of 4 ventricles each. *P <0.01 with respect to pCAGs-I-GFP electroporated 
embryos. C. Effect of TH gain-of-function on ventricular gene expression. Whole-
mount ISH for VMHC1 and Irx4 in embryos as in (A). The posterior regression of 
VMHC and Irx4 expression is indicated by the red arrows. In supplementary materials 
this figure is reproduced including GFP expression (Fig. S4). 
Figure 4. Effect of TH knockdown on anterior-posterior heart tube 
patterning and specification of chambers. A. Whole-mount ISH for AMHC1, Tbx5 
and VMHC1 in embryos electroporated with either luciferase MO or with TH MO. 
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Note also the decrease in AMHC1 and Tbx5 expression in the TH MO treated (arrow) 
versus de luciferase MO control (arrowhead). On the contrary, VMHC1 expression did 
not change or showed a mild increase. B. Light microscopy of st. 10 and 12 non-
electroporated or electroporated embryos with either luciferase MO or with TH MO. 
The heart tube of the TH morphants show abnormal morphogenesis displaying an 
atrophic sino-atrial region and oversized ventricular region (in embryos with 
comparable number of somites and similar prosencephalon development). The 
ventricular segment is outlined in blue and the sino-atrial segment in yellow. 
Figure 5. TH, AMHC1 and Tbx5 expression are controlled by retinoic acid. 
A. Increased TH, AMHC1 and Tbx5 expression by retinoic acid. St. 5 embryos with a 
bead soaked in either DMSO (vehicle) or RA implanted lateral to one of the bilateral 
heart fields (yellow bead) were then analyzed by whole-mount ISH at st. 12. The 
expanded expression of TH, AMHC1 and Tbx5 in the heart tube and in the inflow tract 
are indicated by arrows, and their normal expression domains are outlined by yellow 
dotted-lines. B. Decreased TH, AMHC1 and Tbx5 expression by retinoic acid synthesis 
inhibition. St. 5 embryos were treated with ethanol (vehicle) or 10 mmol/L citral and 
analyzed by ISH at st. 10-11. C. Scheme of the interplay of RA and TH in chamber-
specific genes regulation.  
Table 1. Effect of TH overexpression on heart rate 
 
 
 
 
 
 
*BMP: Beats per minute 
The results represent the mean ± SD 
 Non-electroporated 
(n=10) 
pCAGs-I-GFP 
(n=10) 
pCAGs-TH-I-GFP 
(n=10) 
BPM* 100.6 +/- 3.53 100.5 +/- 3.02 53.1 +/- 2.68 
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Supplementary Methods 
Whole Embryo culture. 
Embryos were staged according to Hamburger and Hamilton (1). The early 
chick (EC) embryo culture is an improved variant of the original New culture (2) as 
described by Chapman et al. (3). In essence, the egg is open and the albumen discarded. 
The yolk containing the embryo of the desired stage (st.) is laid on a Petri dish, cleaning 
with tissue the remaining albumen. A filter paper (20x20 mm Whatman) cut in the 
center is placed around the embryonic area, and the surrounding viteline membrane is 
cut out. The embryo containing filter piece is carefully lifted and placed ventral-side-up 
on a 35 mm Petri dish half-full with semisolid culture medium. This medium is 50% 
123 mM NaCl / 0.6% agar and 50% albumen from non-incubated eggs. 
Bead implantation. 
L-DOPA, Dopamine and meta-hydroxybenzylhydrazine (mHBH) were 
dissolved in PBS, 3-Iodo-Tyrosine (3I-Tyr) was dissolved in 1 N NaOH, and all-trans-
retinoic acid (RA) was dissolved in dimethyl sulphoside (DMSO), (all from Sigma, St. 
Louis, MO). For L-DOPA, Dopamine, 3I-Tyr and mHBH treatments, heparin-coated 
acrylic beads (150-200 µm diameter, Sigma) were used, whereas for RA, AG1-X2 ion-
exchange resin beads (150-200µm diameter, BioRad) were used. Heparin-coated acrylic 
beads were washed in phosphate-buffered saline (PBS) 3 times for 10 min each and 
then placed in a Petri dish containing a drop of the testing solution. After 2 h of 
incubation, individual beads were picked up with tweezers and implanted into a pocket 
opened between the epiblast and endoderm of cultured embryos at st. 5, in the desired 
location: medial or lateral to one of the bilateral heart field, as previously described (4). 
AG1-X2 ion-exchange resin beads were first soaked in 10 g/ml RA for 20 min at room 
temperature, followed by staining in 0.05% Neutral Red for 10 min, and rinsed three 
times in 0.9% saline solution. Beads were placed in the embryo as described above. 
Control beads were soaked in PBS for experiments with L-DOPA, dopamine and 
mHBH treatments, in 1 mM NaOH for experiments with 3I-Tyr, and in DMSO for RA 
experiments. After 6-18 hours of additional incubation, embryos were fixed overnight in 
4% PFA and processed for whole mount ISH or immunohistochemistry. 
Citral treatment. 
Cultured embryos at st. 5 were treated with citral (3,7-dimethyl-2,6-octadienal, 
Sigma), an inhibitor of retinoic acid synthesis (5). Stock solution of citral (1 M in 
Supplementary Material - Other
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ethanol 100%) was diluted in PBS to 10 mM. Control embryos received ethanol 1% in 
PBS. Twenty microliters of test solution were applied over the embryo as described by 
Hochgreb et al. (6). Embryos were photographed at st. 10-11 under bright light, fixed 
overnight in 4% PFA, and processed for whole mount ISH. 
Electroporation of precardiac primitive streak cells. 
For electroporation we used a modified technique previously described by Colas 
and Schoenwolf (7). Cultured st. 3 or st. 3+ embryos were transferred ventral-side-up to 
a Petri dish containing the tungsten cathode electrode (tip 2 mm long and 100 m 
diameter, CUY701P2E, Nepagene) embedded in the agarose. The primitive streak of the 
embryo was aligned with the cathode located underneath. Next, a plasmid or 
oligonucleotide DNA solution was microinjected using an Inject + Matic microinjector 
system (INJECT + MATIC, Geneva) into the desired region of the primitive streak. 
Immediately after DNA injection, the anode (L-shape platinum, tip 2 mm long and 300 
m diameter, CUY613P2, Nepagene) was placed just over the injected primitive streak 
area, and electric pulses were applied. A train of five square wave pulses (40-ms 
duration at 5V with 999-ms intervals) was applied using a square wave TSSS20 
Ovodyne Electroporator (Intracel).  
The mixture for plasmid or oligonucleotide DNA injection, was prepared 
immediately before electroporation. For plasmid (pCAGs- I-GFP or pCAGs-TH-I-GFP 
vector) a working solution that contained the plasmid to a final concentration of 1.5 
µg/µl, 1/10 volume of 60% (wt/vol) sucrose and 1/10 volume of 0.5% (wt/vol) fast 
green FCF (Sigma). For morpholino oligonucleotide (fluorescein-labelled luciferase or 
TH morpholino, Gene Tools LLC), a working solution that contained the morpholino to 
a final concentration of 1 mM, 0.3 µg/µl pBluescript plasmid DNA as a carrier, 1/10 
volume of 60% (wt/vol) sucrose, 1/10 volume of 0.5% (wt/vol) fast green FCF was 
prepared. 
After electroporation, the embryos were transferred to the agar-albumen dish, 
returned to the incubator, and allowed to develop until they reached the desired stage. 
All the embryos were photographed under bright and fluorescent light (Nikon digital, 
SIGHT DS-U1). Embryos were selected according to the location and extent of the 
electroporation. The selected embryos were fixed in 4% PFA and processed for analysis 
of gene expression (ISH) and/or immunochemistry. A group of embryos electroporated 
were selected for RNA isolation; the atria and ventricles were collected and directly 
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frozen on dry ice for RT-qPCR analysis. In each experiment, n refers to the number of 
embryos successfully labelled and studied.  
HPLC analysis. 
St.8 and st.10 embryos were collected in 100 μl 0.3 N HClO4 containing 0.4 mM 
sodium bisulphite and 0.4 mM EDTA. DHBA (100 pmol/ml) was added as an internal 
standard. Samples were sonicated and centrifuged at 15,000 g for 5 min at 4°C. The 
catecholamine content in 40 μl of the supernatant fraction was quantified by high-
performance liquid chromatography (HPLC) with colorimetric detection, as described 
(8).  
Whole-Mount In situ Hybridization (ISH). 
In situ hybridization was performed using as probes the chick AMHC1 (9), 
VMHC1 (10), cNkx2.5 (11), Irx4 (12) and Bmp2 (13). All these probes were kindly 
provided by others labs. The cTH probe (1570-bp), and cTbx5 probe (1577-bp) were 
generated by reverse transcription (RT) from st. 10 total embryo RNA using the 
Invitrogen Superscript III kit and an oligo-dT primer, followed by PCR with the specific 
primers listed below. The amplified products were cloned into the pCRII TOPO shuttle 
vector (Invitrogen), and their identity and orientation were confirmed by sequencing. 
Selected embryos were fixed overnight in 4% PFA, dehydrated in a graded 
methanol series in PBT (PBS, 0.1% Tween 20) and stored in 100% methanol at -20°C 
until further processing. For the probe hybridization step, embryos were rehydrated and 
permeabilized three times for 20 min in detergent solution (1% IGEPAL, 1% SDS, 
0.5% deoxycholate, 50 mM Tris–HCl, pH 8.0, 1 mM EDTA, pH 8.0, 150 mM NaCl) 
then fixed for 20 min in 4% PFA. After several washes in PBT to remove the fixative, 
the embryos were incubated in prehybridization solution (50% formamide, 5x SSC, pH 
4.5, 2% SDS, 2% BBR, 250 µg /ml tRNA, 100 µg/ml Heparin) at 65°C for 2 h followed 
by the addition of 10 µg/ml of the appropriate probe and further overnight incubation at 
the selected hybridization temperature. Then embryos were washed twice for 30 min 
with solution X (50% formamide, 2xSSC, pH 4.5, 1% SDS), at the hybridization 
temperature followed by two washes for 30 min. at room temperature in MABT (150 
mM NaCl, 100 mM Maleic acid, 0.1% Tween 20). For the antibody step, nonspecific 
binding was blocked by incubating 1 h in blocking solution (MABT containing 2% 
blocking reagent, Roche). Embryos were incubated with AP-conjugated anti-DIG 
antibody (1:2000 in blocking solution, Roche) overnight at 4°C with rocking. The 
embryos were washed in MABT six times for 30 min at room temperature, followed by 
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two washes for 10 min in NTMT (100 mM NaCl, 100 mM Tris–HCl, pH 9.5, 50 mM 
MgCl2, 0.1% Tween 20). The AP conjugated anti-DIG antibody was detected by a 
mixture of 4.5 µl NBT/3.75 µl BCIP (Roche) in 1 ml NTMT, pH 9.5. The reaction was 
stopped by washing in PBT once the required staining intensity was achieved, then 
embryos were fixed in 4% PFA overnight and photographed. 
Embryos for histology were dehydrated with an ethanol series and then cleared 
in isopropanol and processed for paraplast embedding. Serial transverse sections were 
cut at 15 μm. 
Immunohistochemistry. 
Whole mount immunohistochemistry was performed as previously described by 
us (14), using the MF20 antibody [1/100, Hybridoma Bank, Developmental Studies 
(15)] followed by anti-mouse Ig-HRP antibody (1/200, Jackson Immunoresearch 
Laboratories, West Grove, PA), or the polyclonal rabbit anti-TH serum (1/100, 
Chemicon) followed by anti-rabbit Ig-HRP antibody (1/1,000 Chemicon). To obtain a 
brown reaction product, we performed a standard peroxidase reaction according to the 
manufacturer´s instructions (solution obtained from diaminobenzidine [DAB] tablets, 
Sigma). When indicated, whole mount immunochemistry was performed after  ISH. 
Videotaping. 
Control- and TH-electroporated groups of embryos in EC culture were incubated 
in a humidified chamber with a video recording system, at 38 ºC for 60 min. At the end 
of this period, the embryos were recorded for 5 min and heart beats were counted for 
this time period.  
Mouse embryos. 
 C57BL/6 mouse embryos were removed from the uterus of pregnant females 
and subsequently dissected from the deciduum. All animals were handled according to 
European Union Guidelines for animal research. 
RNA isolation and standard and quantitative RT-PCR. 
Total RNA from whole embryos or dissected heart regions was isolated with the 
Trizol reagent (Invitrogen) and 2.5 g of RNA was typically reverse transcribed (RT) 
with the Superscript III Kit and random primers (all from Invitrogen). Quantitative PCR 
(qPCR) was performed with the ABI Prism 7900HT Sequence Detection System 
(Applied Biosystems, Weiterstadt, Germany) by using TaqMan Universal PCR Master 
Mix, No-AmpErase UNG (Applied Biosystems) and the probes of the Universal Probe 
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Library (URL, Roche Applied Science) were used for detection. Chick (c) and mouse 
(m) primer sequences and the respective URL probes are listed below.  
Primers and URL probes for qRT-PCR 
Gene Primers       URL  
cTH ACAGCCCCCAGACCATCT (left)    80 
AATCAGCGAATGAAGCTCGT (right) 
cGAPDH  GTCCTCTCTGGCAAAGTCCA (left)   49 
ACCATGTAGTTCAGATCGATGAAG (right) 
 cDBH  TACAAGGTGTCCCTCGATCC (left)   66 
   GCTCGGGGTAACTGACGTT (right) 
 
cAMHC1 CTTTGTCCGCTGTCTCATCC (left)   12 
AGGGGGTTGTCCATCACAC (right) 
cTbx5 GATGAGAACAACGGCTTTGG (left)   8 
AGTCTCGGGGAAGACATGG (right) 
mTH GGAACGGTACTGTGGCTACC (left)   56 
CCTTCAAGAAGTGAGACACATCC (right) 
m18S rRNA TGCGAGTACTCAACACCAACA (left)   70 
TTCCTCAACACCACATGAGC (right) 
 
Primers for standard RT-PCR 
Gene Primers 
 cTH  CACGAGTGAAGATGCCAAC (left) 
   CCCTGTTCCTAGTCTGTAAC (right) 
 cTBX5 AAGCTCGTAACATGGCGGAC (left) 
   TTAGCTGTTCTCGCTCCACT (right) 
 mTH  TCAGTGATGCCAAGGACAAG (left) 
   ATCAAAGGGTCCAGCCAC (right) 
 TH morpholino oligonucleotide 
   GGGTTGGCATCTTCACTCTTCCACG 
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Supplementary tables 
 
Table S1. Ectopic expression of cardiac markers  induced by L-DOPA and dopamine 
 
Table S2. Inhibition of AMHC-1 expression 
  
 
 
 
 
 
 
 
 
Table S3. Effect of TH overexpression on atrial markers 
 
 
 
 
 
 
 
Table S4. Effect of TH overexpression on ventricular markers 
 
 
 
 
 
Table S5. Effect of TH knockdown on anterior-posterior patterning 
 
 
 
 
 
Heparin bead 
soaked in 
cNkx2.5 
(n) 
Tbx5 
(n) 
AMHC1  
(n) 
MF20 
(n) 
Total 
(n) 
PBS (control) 0/9 0/10 0/12 0/15 46 
L-DOPA (10 M) 8/8 9/9 15/15 12/12 44 
Dopamine (10 M) 9/9 9/9 16/16 14/14 48 
Heparin bead  
soaked in 
Decreased AMHC1 
expression (n) 
NaOH (control) 0/12 
3I-Tyr (1 mM) 16/16 
PBS (control) 0/10 
mHBH (1mM) 15/15 
Electroporated 
vector 
Expanded AMHC1 
expression (n) 
Expanded Tbx5 
expression (n) 
pCAGs-I-GFP 0/21    0/15 
pCAGs-TH-I-GFP 27/27    18/18 
Electroporated 
vector 
Decreased VMHC1 
expression (n) 
Decreased Irx4 
expression (n) 
pCAGs-I-GFP 0/8    0/11 
pCAGs-TH-I-GFP 12/12    15/15 
MO applied Decreased AMHC1 
expression (n) 
Decreased Tbx5 
expression (n) 
Decreased 
VMHC1 
expression (n) 
Luciferase MO 0/12 0/8    0/9 
TH MO 18/18 9/9    0/11 
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Table S6. Number of embryos affected by retinoic acid treatment 
 
Table S7. Number of embryos affected by citral treatment 
 
 
 
 
 
AG1-X2 bead  
soaked in 
Expanded TH  
expression (n) 
Expanded AMHC1 
expression (n) 
Expanded Tbx5 
expression (n) 
DMSO (control) 0/12 0/10    0/6 
RA (10 g/ml) 18/18 14/14    9/9 
Treatment Decreased TH  
expression (n) 
Decreased AMHC1 
expression (n) 
Decreased Tbx5 
expression (n) 
Ethanol (control) 0/5 0/5    0/4 
Citral (10 mmol/L) 12/12 9/9    6/6 
 8 
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Figure S1. TH expression parallels that of AMHC1 and Tbx5 during cardiac tube formation. Whole-mount ISH for TH, AMHC1 
and Tbx5. a-f correspond to transverse paraffin sections at the levels indicated by the lines. Note that at st. 8 TH mRNA as well as 
that of AMHC1 and Tbx5 are restricted to the splanchnic mesoderm of the endocardial tubes (a, c and e), and later it is 
predominantly expressed in the myocardial layer of the atriogenic region. The three genes are widely expressed in the endocardial
tubes (st. 8) and in the fusing cardiac primordia (st. 9). Later (st. 12), the three mRNAs concentrate at the posterior part of the 
primitive heart tube, the prospective atrial region (b, d and f). 
Supplementary Material - Other
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Figure S2. Effect of dopamine on BMP2 expression. Left drawing corresponds to a st. 5 embryo with a bead implanted 
lateral (yellow bead) or medial (red bead) to one of the bilateral heart fields. Beads were soaked in either PBS (vehicle), or a
solution of 10 µmol/L dopamine. Stage 8 (A-B) or st. 10 (C-D) embryos were subjected to whole-mount ISH for BMP2. A, B. 
Dopamine beads implanted medial to the heart field increased the expression of BMP2 in the endocardial tube ipsilateral to 
the bead (arrow), but not the control bead (arrowhead). C, D. Ectopic tissue adjacent to the bead coated with dopamine  and 
implanted medial to the heart field expressed BMP2 (arrow). Ectopic tissue or labelling was not detected around the control 
bead (arrowhead). 
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Figure S3. Co-expression of TH and the reporter gene in electroporated embryos. A. Embryo at st.3 injected and 
electroporated in the primitive streak (asterisk) with pCAGs-TH-I-GFP construct. B. Fluorescent light photography of 
electroporated embryos at st. 7. C.  Whole-mount ISH for TH of embryo showed in B. D. TH immunostaining after Whole-
mount ISH for TH of the same embryo showed in B and C. 
St. 8 electroporated embryos showed aproximatly 2.4-fold increase in L-DOPA content measured by HPLC
GFP GFPVMHC1 VMHC1
pCAGs-I-GFP pCAGs-TH-I-GFP
VMHC1
Non-electroporated
GFP Irx4 Irx4GFPIrx4
Figure S4. Effect of TH gain-of-function on ventricular gene expression. Whole-mount ISH for VMHC1 and Irx4 in non-
electroporated embryos, and in embryos electroporated with either the control construct (pCAGs-I-GFP) or with the TH expressing 
construct (pCAGs-TH-I-GFP). Visualization of GFP expression for the embryos processed for ISH is shown in the corresponding 
left panels. The posterior regression of VMHC and Irx4 expression is indicated by the red arrows. 
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Figure S5. Expression of TH mRNA in mouse embryos. A. Standard RT-PCR of RNA 
from whole embryos at the indicated days of development. TH was expressed in whole 
mouse embryo since E6.5 (the earliest analyzed stage). B. Quantitative RT-PCR of RNA from 
the heart of embryos at the indicated days. The levels of TH mRNA were normalized to 18S 
rRNA levels. TH  transcripts were detected in the mouse heart from E8.5 (the earliest 
analyzed stage) onwards. The results represent the mean ± SD of two experiments.
Supplementary Material - Video, Audio
Click here to download Supplementary Material - Video, Audio: Movie O. Brtulos.wmv
